The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics of prostate cancer survivors exposed to ADT and enrolled in a fall prevention exercise trial: Comparison of men with confirmed fall history to men with fall risk factors.
 
Kerri M. Winters-Stone
No Relationships to Disclose
 
Sydnee Stoyles
No Relationships to Disclose
 
Christopher L. Amling
No Relationships to Disclose
 
Arthur Hung
Research Funding - Janssen Oncology (Inst)
 
Nathan Dieckmann
No Relationships to Disclose
 
Fuzhong Li
No Relationships to Disclose
 
Fay B. Horak
Employment - APDM Wearable Technologies
Stock and Other Ownership Interests - APDM Wearable Technologies
Honoraria - Autobahn Therapeutics
Consulting or Advisory Role - Sanofi
Research Funding - Autobahn Therapeutics; Biogen; Pfizer
 
Deanne Tibbitts
No Relationships to Disclose
 
Tomasz M. Beer
Stock and Other Ownership Interests - Arvinas; Salarius Pharmaceuticals
Consulting or Advisory Role - Arvinas; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Constellation Pharmaceuticals; GRAIL; Janssen; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolero Pharmaceuticals
Research Funding - Alliance Foundation Trials (Inst); Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Freenome (Inst); GRAIL (Inst); Harpoon Therapeutics (Inst); Janssen Research & Development (Inst); Medivation (Inst); Sotio (Inst); Theraclone Sciences (Inst); Zenith Epigenetics (Inst)